Novel immunotherapies in GU malignancies. - Wikidata - awgldk - TriplyDB

Novel immunotherapies in GU malignancies.

Novel immunotherapies in GU malignancies.

http://www.wikidata.org/entity/Q38092022

about

Novel immunotherapies in GU malignancies.

http://www.wikidata.org/entity/Q38092022

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Novel immunotherapies in GU malignancies.

@en

type

label

Novel immunotherapies in GU malignancies.

@en

prefLabel

Novel immunotherapies in GU malignancies.

@en

P1433

Q38092022-3566BBF3-7801-4554-A12F-C10E5BD7F184

P1476

Q38092022-263350A5-7CA6-4545-B43A-F78F196809E8

P2093

Q38092022-91A5771E-2B70-4452-8B3F-17B2BA19EFE0

Q38092022-E315CA25-3B1E-4831-B64A-74B89F7D9BED

P2860

Q38092022-00581F68-D647-439E-AFA4-F4496A1B4C67

Q38092022-03D9206A-FF6C-4E3F-AA0E-D7C5D6F399D8

Q38092022-12CF50E8-9C11-4837-92CE-BE960A52030A

Q38092022-17139E17-2606-4A1E-9C3D-54048F7B1B8C

Q38092022-1D9D2CF5-8552-471C-9060-E1060ABB44E4

Q38092022-1ED9291C-7100-411C-B099-A8C0CE86855E

Q38092022-2740272C-31EE-4C78-88E6-F17A25D89C23

Q38092022-277FBD1C-47AC-47BF-9B9A-5EDA1CFBB468

Q38092022-2A770044-01C6-486E-9E13-3A8002A35E78

Q38092022-2B92A410-13F7-4B0A-88C1-2A842F207714

P2888

Q38092022-466ADCAA-8C71-4C6C-BA9F-F4CEC9F55AA1

P304

Q38092022-34D96288-AA40-4EB7-BF20-BF6F42ECA5D9

P31

Q38092022-0316A8D2-58F0-45D4-84EC-8A23A105C59F

P356

Q38092022-AD1629DD-A278-4299-9F37-E0C7EA1FA428

P433

Q38092022-C11F29BB-E419-4458-AA58-39F19DFD2C6D

P478

Q38092022-7BA580B5-DADE-484B-860A-DC3B3D5B5497

P577

Q38092022-36640211-0604-4A55-BF20-664FFE0817EB

P6179

Q38092022-AB84FC40-4B80-4994-9AED-3C2C99A7D5CC

P698

Q38092022-6C1E9016-9AEC-47D2-BB0E-4C78239E3D3F

P356

S11912-013-0306-8

P1433

Current Oncology Reports

P1476

Novel immunotherapies in GU malignancies.

@en

P2093

Alexandra Drakaki

http://www.w3.org/2001/XMLSchema#string

David F McDermott

http://www.w3.org/2001/XMLSchema#string

P2860

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Cancer statistics, 2010

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

The blockade of immune checkpoints in cancer immunotherapy

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Sorafenib in advanced clear-cell renal-cell carcinoma

Cancer statistics, 2009

P2888

s11912-013-0306-8

P304

224-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-013-0306-8

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1033003643

http://www.w3.org/2001/XMLSchema#string

P698

23519772

http://www.w3.org/2001/XMLSchema#string